AdvancingCell Stabilization Technology

Cellphire, Inc. is a biotechnology company focusing on cell stabilization technology with a current emphasis on blood platelets.

Cellphire has developed a proprietary method for the long-term stabilization of
platelets in the dry state.

Thrombosomes® are currently in a Phase 1 clinical trial. Learn more.
For more Cellphire product development efforts, visit the Our Technology page.

News Releases

January 15, 2020 – Cellphire, the global leader in long-term stabilization and storage of platelet...Read More »

October 24, 2019 - Data from a phase 1, open-label, multi-center safety trial of lyophilized platele...Read More »

July 18, 2019 – Cellphire, Inc., the global leader in long-term cell stabilization and storage of ...Read More »

More Articles »

Have Questions?Reach us here

Please enter your information below

Cellphire Veterinary Subsidiary BODEVET, INC. Launches First Commercial Product 

Copyright © 2020 // Website Developed by